Clinical trials
Phase 1/2 Nasopharyngeal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2007 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2019 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 6 |
| Recruiting | 3 |
| Terminated | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National University Hospital, Singapore | 2 |
| Sun Yat-sen University | 2 |
| Alberta Health services | 1 |
| Atara Biotherapeutics | 1 |
| Avenzo Therapeutics, Inc. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Cullinan Therapeutics Inc. | 1 |
| Duke University | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| Hope Cancer Institute, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Neoplasms | 20 |
| Nasopharyngeal Carcinoma | 6 |
| Head and Neck Neoplasms | 5 |
| Salivary Gland Neoplasms | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Epstein-Barr Virus Infections | 4 |
| Hypopharyngeal Neoplasms | 4 |
| Laryngeal Neoplasms | 4 |
| Mouth Neoplasms | 4 |
| Oropharyngeal Neoplasms | 4 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.